Narcolepsy Therapeutics Market 2025 to 2034
Narcolepsy Therapeutics Market 2025 to 2034
Narcolepsy Therapeutics Market (By Treatment: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy; By Product: Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 4.12 Bn
Forecast Year, 2034
USD 8.04
CAGR, 2025 - 2034
7.70%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global narcolepsy therapeutics market, valued at USD 4.12 billion in 2025, is projected to reach USD 8.04 billion by 2034, expanding at a CAGR of 7.7%, driven by rising prevalence, awareness, and advancements in treatment options.
Narcolepsy Therapeutics Market Size Analysis
Narcolepsy Therapeutics Market Size By Treatment 2025 to 2034 (USD Billion)
| Treatment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Narcolepsy With Cataplexy | 0.69 | 0.74 | 0.80 | 0.86 | 0.94 | 1.00 | 1.07 | 1.16 | 1.25 | 1.34 |
| Narcolepsy Without Cataplexy | 1.37 | 1.48 | 1.59 | 1.72 | 1.85 | 2.00 | 2.14 | 2.31 | 2.49 | 2.67 |
| Secondary Narcolepsy | 2.06 | 2.21 | 2.39 | 2.57 | 2.76 | 2.98 | 3.21 | 3.45 | 3.73 | 4.02 |
Narcolepsy Therapeutics Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Central Nervous System Stimulants | 0.28 | 0.30 | 0.32 | 0.35 | 0.37 | 0.40 | 0.43 | 0.47 | 0.50 | 0.54 |
| Sodium Oxybate | 0.55 | 0.59 | 0.64 | 0.69 | 0.74 | 0.80 | 0.86 | 0.92 | 1.00 | 1.08 |
| Selective Serotonin Reuptake Inhibitor | 0.82 | 0.89 | 0.96 | 1.03 | 1.11 | 1.20 | 1.28 | 1.39 | 1.49 | 1.61 |
| Tricyclic Antidepressants | 1.10 | 1.18 | 1.27 | 1.37 | 1.47 | 1.59 | 1.72 | 1.84 | 1.99 | 2.13 |
| Others | 1.37 | 1.48 | 1.59 | 1.71 | 1.84 | 1.99 | 2.14 | 2.30 | 2.48 | 2.68 |
Narcolepsy Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.41 | 0.45 | 0.48 | 0.52 | 0.56 | 0.60 | 0.64 | 0.70 | 0.75 | 0.81 |
| LAMEA | 0.83 | 0.89 | 0.96 | 1.03 | 1.11 | 1.20 | 1.29 | 1.39 | 1.50 | 1.61 |
| Europe | 1.23 | 1.33 | 1.43 | 1.54 | 1.66 | 1.79 | 1.93 | 2.07 | 2.24 | 2.41 |
| Asia-Pacific | 1.65 | 1.77 | 1.91 | 2.06 | 2.21 | 2.38 | 2.57 | 2.76 | 2.98 | 3.21 |
Narcolepsy Therapeutics Market Size to Hit USD 8.04 Billion by 2034
The global narcolepsy therapeutics market size surpassed USD 4.12 billion in 2025 and is predicted to reach around USD 8.04 billion by 2034 with a registering a CAGR of 7.70%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
